The -itis.

This educational review reminds us that, while immune checkpoint inhibitors are opening the door to more cancer cures via completely novel mechanisms, that door’s letting in completely novel toxicities including diabetic ketoacidosis with no prior diabetes diagnosis and even reactivation of tuberculosis. | NCI 2019